|
Originally published In Press as doi:10.1074/jbc.C600208200 on September 15, 2006
J. Biol. Chem., Vol. 281, Issue 44, 32941-32945, November 3, 2006
Evidence for a Matriptase-Prostasin Proteolytic Cascade Regulating Terminal Epidermal Differentiation*
Sarah Netzel-Arnett 1,
Brooke M. Currie 1,
Roman Szabo ,
Chen-Yong Lin¶,
Li-Mei Chen||,
Karl X. Chai||,
Toni M. Antalis ,
Thomas H. Bugge 2, and
Karin List
From the
Center for Vascular and Inflammatory Diseases and Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, the Proteases and Tissue Remodeling Unit, NIDCR, National Institutes of Health, Bethesda, Maryland 20892, the ¶Lombardi Cancer Center, Georgetown University Medical Center, Washington, D. C. 20007, and the ||Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32816-2364
Recent gene ablation studies in mice have shown that matriptase, a type II transmembrane serine protease, and prostasin, a glycosylphosphatidylinositol-anchored membrane serine protease, are both required for processing of the epidermis-specific polyprotein, profilaggrin, stratum corneum formation, and acquisition of epidermal barrier function. Here we present evidence that matriptase acts upstream of prostasin in a zymogen activation cascade that regulates terminal epidermal differentiation and is required for prostasin zymogen activation. Enzymatic gene trapping of matriptase combined with prostasin immunohistochemistry revealed that matriptase was co-localized with prostasin in transitional layer cells of the epidermis and that the developmental onset of expression of the two membrane proteases was coordinated and correlated with acquisition of epidermal barrier function. Purified soluble matriptase efficiently converted soluble prostasin zymogen to an active two-chain form that formed SDS-stable complexes with the serpin protease nexin-1. Whereas two forms of prostasin with molecular weights corresponding to the prostasin zymogen and active prostasin were present in wild type epidermis, prostasin was exclusively found in the zymogen form in matriptase-deficient epidermis. These data suggest that matriptase, an autoactivating protease, acts upstream from prostasin to initiate a zymogen cascade that is essential for epidermal differentiation.
Received for publication, August 4, 2006
, and in revised form, September 11, 2006.
* This work was supported by the National Institutes of Health (NIH) Intramural program and by Grant DAMD-17-02-1-0693 from the Department of Defense (DOD) (to T. H. B.), by National Institutes of Health Grant CA098369 and the Lance Armstrong Foundation (to T. M. A.), NIH Grant HL07698 (to S. N.-A.), DOD Grant DAMD17-02-1-0338 (to K. X. C.), NIH Grant HD 40241 (to L-M. C.), and by NIH Grants R01-CA-104944 and R01-CA-096851 (to C.-Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. We dedicate this paper to the memory of our friend Robert B. Dickson who passed away June 24, 2006.
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed: Proteases and Tissue Remodeling Unit, NIDCR, NIH, 30 Convent Dr., Rm. 211, Bethesda, MD 20892. Tel.: 301-435-1840; Fax: 301-402-0823; E-mail: thomas.bugge{at}nih.gov.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Szabo, J. P. Hobson, K. Christoph, P. Kosa, K. List, and T. H. Bugge
Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice
Development,
August 1, 2009;
136(15):
2653 - 2663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Ramsay, J. D. Hooper, A. R. Folgueras, G. Velasco, and C. Lopez-Otin
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
Haematologica,
June 1, 2009;
94(6):
840 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kojima, S. Tsuzuki, T. Fushiki, and K. Inouye
Role of the Stem Domain of Matriptase in the Interaction with its Physiological Inhibitor, Hepatocyte Growth Factor Activator Inhibitor Type I
J. Biochem.,
June 1, 2009;
145(6):
783 - 790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Szabo, P. Kosa, K. List, and T. H. Bugge
Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality
Am. J. Pathol.,
June 1, 2009;
174(6):
2015 - 2022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sandilands, C. Sutherland, A. D. Irvine, and W. H. I. McLean
Filaggrin in the frontline: role in skin barrier function and disease
J. Cell Sci.,
May 1, 2009;
122(9):
1285 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Rickert, P. Kelley, N. J. Byrne, R. E. Diehl, D. L. Hall, A. M. Montalvo, J. C. Reid, J. M. Shipman, B. W. Thomas, S. K. Munshi, et al.
Structure of Human Prostasin, a Target for the Regulation of Hypertension
J. Biol. Chem.,
December 12, 2008;
283(50):
34864 - 34872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Janciauskiene, I. Nita, D. Subramaniyam, Q. Li, J. R. Lancaster Jr., and S. Matalon
{alpha}1-Antitrypsin Inhibits the Activity of the Matriptase Catalytic Domain In Vitro
Am. J. Respir. Cell Mol. Biol.,
December 1, 2008;
39(6):
631 - 637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nagaike, M. Kawaguchi, N. Takeda, T. Fukushima, A. Sawaguchi, K. Kohama, M. Setoyama, and H. Kataoka
Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice
Am. J. Pathol.,
November 1, 2008;
173(5):
1464 - 1475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Szabo, J. P. Hobson, K. List, A. Molinolo, C.-Y. Lin, and T. H. Bugge
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
J. Biol. Chem.,
October 24, 2008;
283(43):
29495 - 29504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Myerburg, E. E. McKenna, C. J. Luke, R. A. Frizzell, T. R. Kleyman, and J. M. Pilewski
Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis
Am J Physiol Lung Cell Mol Physiol,
May 1, 2008;
294(5):
L932 - L941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Desilets, F. Beliveau, G. Vandal, F.-O. McDuff, P. Lavigne, and R. Leduc
Mutation G827R in Matriptase Causing Autosomal Recessive Ichthyosis with Hypotrichosis Yields an Inactive Protease
J. Biol. Chem.,
April 18, 2008;
283(16):
10535 - 10542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. List, B. Currie, T. C. Scharschmidt, R. Szabo, J. Shireman, A. Molinolo, B. F. Cravatt, J. Segre, and T. H. Bugge
Autosomal Ichthyosis with Hypotrichosis Syndrome Displays Low Matriptase Proteolytic Activity and Is Phenocopied in ST14 Hypomorphic Mice
J. Biol. Chem.,
December 14, 2007;
282(50):
36714 - 36723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Lee, I-C. Tseng, Y. Wang, K.-i. Kiyomiya, M. D. Johnson, R. B. Dickson, and C.-Y. Lin
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain
Am J Physiol Cell Physiol,
July 1, 2007;
293(1):
C95 - C105.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|